Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
NKTR
#1941
Nektar Therapeutics
73.250
0
USD
+4.11%
Sektor:
Gesundheitswesen
Basis:
USD
Gewinnwährung:
USD
Tagesspanne
Jahresspanne
Tagesänderung
+4.11%
Monatliche Änderung
-0.03%
6 month change
-0.03%
Jahresänderung
-0.03%
Vorheriger Schlusskurs
70.360
0
Open
73.250
0
Bid
73.250
0
Ask
73.253
0
Low
73.250
0
High
73.250
0
Volumen
66
Märkte
Aktien
Gesundheitswesen
NKTR
Open full chart
Financials
Overview
Finanzbericht
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
12.3 M
12.41 M
12.41 M
19.02 M
20.34 M
—
Valuation ratios
Enterprise value
—
—
—
448.45 M
1.12 B
—
Price to earnings ratio
—
—
—
-2.98
-7.25
—
Price to sales ratio
—
—
—
4.79
13.27
—
Price to cash flow ratio
—
—
—
1.95
4.49
—
Price to book ratio
—
—
—
2.43
4.9
—
Enterprise value to EBITDA ratio
—
—
—
—
-6.24
—
Profitability ratios
Return on assets %
0.12
-0.02
0.2
0.2
0.12
0.49
Return on equity %
0.76
-0.12
3.7
1.72
0.42
5.72
Return on invested capital %
233.59
-106.05
321.82
316.55
297.28
829.6
Gross margin %
81.62
72.66
100
100
100
372.66
Operating margin %
142.37
-49.18
425.76
324.21
268.63
969.43
EBITDA margin %
—
-109.97
-580.57
-406.73
-344.29
-1 441.57
Net margin %
153.61
-24.89
486.44
372.2
301.29
1 135.04
Liquidity ratios
Quick ratio
4.24
4.26
—
—
—
—
Current ratio
4.24
4.26
3.24
2.61
4.24
14.35
Inventory turnover
0.61
—
—
—
—
—
Asset turnover
0.07
0.1
0.04
0.05
0.05
0.23
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
3.15
3.37
3.49
3.25
2.57
12.68
EBIT per share
-2.53
-2.45
-4.41
-3.29
-2.22
-12.37
EBITDA per share
—
-2.34
-4.32
-3.23
-2.14
-12.03
Total debt per share
—
—
—
—
—
—
Cash per share
17.53
18.62
15.55
12.49
14.26
60.91
Net current asset value per share
20.54
19.06
16.35
13.24
14.85
63.5
Tangible book value per share
3.5
4.43
0.98
1.72
4.49
11.62
Working capital per share
15.69
14.58
11.31
8.18
11.35
45.41
Book value per share
3.5
4.43
0.98
1.72
4.49
11.62
Nachrichten
Oppenheimer hebt Kursziel für Nektar Therapeutics auf 140 US-Dollar an
Oppenheimer raises Nektar Therapeutics price target to $140
Nektar Therapeutics-Aktie markiert neues 52-Wochen-Hoch bei 76,30 US-Dollar
Nektar Therapeutics stock hits 52-week high at 76.3 USD
Nektar Therapeutics: Kapitalbasis für F&E-Expansion gestärkt
Earnings call transcript: Nektar Therapeutics Q4 2025 shows cash boost and R&D expansion
Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates
Esperion Therapeutics (ESPR) Misses Q4 Earnings Estimates
Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for
Nektar Therapeutics auf der TD Cowen Konferenz: Fokus auf Immunologie
Wall Street Analysts Think Nektar (NKTR) Could Surge 89.8%: Read This Before Placing a Bet
Nektar Therapeutics stock hits 52-week high at 75.19 USD